The Emerging Role of NANOG as an Early Cancer Risk Biomarker in Patients with Oral Potentially Malignant Disorders
Juan Carlos de Vicente(Universidad de Oviedo), Juana García-Pedrero(Universidad de Oviedo)
Cited by 41
Related Papers
Impact of PI3K/AKT/mTOR pathway activation on the prognosis of patients with head and neck squamous cell carcinomas
|Oncotarget|2016|77
Macrophages in Oral Carcinomas: Relationship with Cancer Stem Cell Markers and PD-L1 Expression
|Cancers|2020|51
A Novel Role For Nanog As An Early Cancer Risk Marker In Patients With Laryngeal Precancerous Lesions
|Scientific Reports|2017|42